---
schema_version: "secwatch.filing_event.v1"
accession: "0001079973-22-001040"
form_type: "8-K"
ticker: "CDIO"
cik: "0001870144"
company_name: "Cardio Diagnostics Holdings, Inc."
filed_at: "2022-08-26T23:59:59+00:00"
generated_at: "2026-06-23T21:09:32.566250+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "medium"
source: SEC EDGAR
---

# Mana Capital provides investor presentation for proposed Cardio Diagnostics merger

## Summary
- Investor presentation first made available on August 26, 2022, for the business combination with Cardio Diagnostics.
- Merger Agreement entered May 27, 2022; Cardio to become wholly owned subsidiary of Mana, renamed Cardio Diagnostics Holdings Inc.
- Presentation will be used to solicit stockholder approval; Form S-4 proxy/prospectus filed with SEC.

## SEC filing metadata
- accession: 0001079973-22-001040
- form_type: 8-K
- ticker: CDIO
- cik: 0001870144
- company_name: Cardio Diagnostics Holdings, Inc.
- filed_at: 2022-08-26T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: medium
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1870144/000107997322001040/0001079973-22-001040-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1870144/000107997322001040/mana_8k-082622.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001079973-22-001040
- JSON: https://secwatch.observer/filing/0001079973-22-001040.json
- Plain text: https://secwatch.observer/filing/0001079973-22-001040.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.